Delivery Order SPE2DB22D3009-SPE2DB24FAQ59
Award Date 2/21/24
Potential Completion Date 2/22/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,250.80 firm-fixed price delivery order is for the supply of 60 tablets of Vimpat 200 mg, a pharmaceutical product. The contract has no set-aside designation and is scheduled for completion on July 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,493.45, is for the delivery of Vimpat 150 mg tablets. It is a firm fixed-price delivery order with an ultimate completion date of April 22, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,608.83, is for the delivery of Vimpat 150 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 7, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization. The contract does not have a set-aside designation,...
- This federal contract award, valued at $2,288.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vimpat 150 mg tablets. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered as a federal contractor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Vimpat 100 mg tablets. The $1,490.52 firm-fixed-price Delivery Order has a completion date of January 3, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for supplying a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,761.12 firm-fixed-price delivery order is for the supply of Vimpat 100 mg tablets to support military and federal healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
- This federal contract award, valued at $5,622.75, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Vimpat 100 mg tablets, a prescription medication, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with an ultimate completion date of April 12, 2024. No set-aside designation was used. Amerisourcebergen...
- This federal contract award, valued at $3,311.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vimpat 100 mg tablets and has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,927.84, is a delivery order for the supply of the pharmaceutical product Vimpat 100 mg tablets. The contract has no set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $1,103.80 firm fixed-price delivery order is for the supply of 4557217534 - Vimpat 150 mg tablets. This order does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products to federal agencies, with a significant focus on serving...